ex dividendBRXeodhd
BRX (BRX) Goes Ex-Dividend Tomorrow
BRX (NYSE:BRX) will go ex-dividend tomorrow, October 02, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
BRX (NYSE:BRX) will go ex-dividend tomorrow, October 02, 2026.
Read moreCAMPBELL'S Co (NASDAQ:CPB) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 07, 2026.
Read moreConcentrix Corp (NASDAQ:CNXC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 07, 2026.
Read moreBTI (NYSE:BTI) will go ex-dividend tomorrow, October 02, 2026.
Read moreCadrenal Therapeutics, Inc. (NASDAQ:CVKD) filed a Form 8-K with the Securities and Exchange Commission on October 07, 2026, disclosing a material event.
Read moreITUB (NYSE:ITUB) will go ex-dividend tomorrow, October 02, 2026.
Read moreMag Magna Corp (OTC:MGNC) filed its annual report (Form 10-K) with the Securities and Exchange Commission on October 07, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Marvell Technology, Inc. (NASDAQ:MRVL) on October 07, 2026.
Read moreRBC Capital reiterated its Outperform rating on Marvell Technology, Inc. (NASDAQ:MRVL) on October 07, 2026.
Read moreJefferies reiterated its Buy rating on Marvell Technology, Inc. (NASDAQ:MRVL) on October 07, 2026.
Read moreJP Morgan reiterated its Overweight rating on Marvell Technology, Inc. (NASDAQ:MRVL) on October 07, 2026.
Read moreWells Fargo reiterated its Overweight rating on Marvell Technology, Inc. (NASDAQ:MRVL) on October 07, 2026.
Read moreWolfe Research reiterated its Outperform rating on Marvell Technology, Inc. (NASDAQ:MRVL) on October 07, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Marvell Technology, Inc. (NASDAQ:MRVL) on October 07, 2026.
Read moreTruist Securities reiterated its Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on October 07, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on October 07, 2026.
Read moreWells Fargo reiterated its Overweight rating on Airbnb, Inc. (NASDAQ:ABNB) on October 07, 2026.
Read moreBarclays reiterated its Overweight rating on Elevance Health Inc. (NYSE:ELV) on October 07, 2026.
Read moreCitigroup reiterated its Buy rating on United Parcel Service, Inc. (NYSE:UPS) on October 07, 2026.
Read moreTruist Securities reiterated its Buy rating on United Parcel Service, Inc. (NYSE:UPS) on October 07, 2026.
Read more